Agile Therapeutics, Inc. Profile Avatar - Palmy Investing

Agile Therapeutics, Inc.

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combinatio…

Drug Manufacturers - Specialty & Generic
US, Princeton [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Agile Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of AGRX's Analysis
CIK: 1261249 CUSIP: 00847L100 ISIN: US00847L3087 LEI: - UEI: -
Secondary Listings
AGRX has no secondary listings inside our databases.